GAP43 and Alzheimer disease: Postmortem neuropathological studies have also demonstrated increased regional CSF GAP-43 concentration and synaptic loss in the hippocampus in patients with AD compared to age-matched controls (Bogdanovic et al., 2000; Rekart et al., 2004).